Regional recurrence after negative sentinel lymph node biopsy for melanoma

Annals of Surgery

Volumn 248, Issue 3, 2008, Pages 378-385

  Carlson, Grant W ^a,b   Page, Andrew J ^a   Cohen, Cynthia ^a   Parker, Douglas ^a   Yaar, Ron ^a   Li, Anya ^a   Hestley, Andrea ^a   Delman, Keith A ^a   Murray, Douglas R ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ERROR; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HAZARD RATIO; HEAD TUMOR; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MULTIVARIATE ANALYSIS; NECK TUMOR; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE BIOPSY; SURVIVAL RATE; SURVIVAL TIME; TIME SERIES ANALYSIS; TUMOR LOCALIZATION; TUMOR VOLUME; EPIDEMIOLOGY; LYMPH NODE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; SKIN TUMOR; SURVIVAL; TUMOR RECURRENCE;

CAUSALITY; FEMALE; HUMANS; LYMPH NODES; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 52449091939     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e3181855718     Document Type: Article

References (25)

1. Zogakis TG, Essner R, Wang HJ, et al. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes. Ann Surg Oncol. 2007;14:1604-1611.
2. Carlson GW, Murray DR, Thourani V, et al. The definition of the sentinel lymph node in melanoma based on radioactive counts. Ann Surg Oncol. 2002;9:929-933.
3. Caraco C, Marone U, Celentano E, et al. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma. Ann Surg Oncol. 2007;14:2662-2667.
4. Morton DL, Thompson JF, Cochran AJ, et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355:1307-1317.
5. Nowecki ZI, Rutkowski P, Nasierowska-Guttmejer A, et al. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma. Ann Surg Oncol. 2006;13:1655-1663.
6. Dalal KM, Patel A, Brady MS, et al. Patterns of first-recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy. Ann Surg Oncol. 2007;14:1934-1942.
7. Li LX, Scolyer RA, Ka VS, et al. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinico- pathologic study of 1152 patients undergoing sentinel lymph node biopsy. Am J Surg Pathol. 2003;27:1197-1202.
8. Yee VS, Thompson JF, McKinnon JG, et al. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Ann Surg Oncol. 2005;12:429-439.
9. Gadd MA, Cosimi AB, Yu J, et al. Outcome of patients with melanoma and histologically negative sentinel lymph nodes. Arch Surg. 1999;134: 381-387.
10. Berman CG, Norman J, Cruse CW, et al. Lymphoscintigraphy in malignant melanoma. Ann Plast Surg. 1992;28:29-32.
11. Eberbach MA, Wahl RL, Argenta LC, et al. Utility of lymphoscintigraphy in directing surgical therapy for melanomas of the head, neck, and upper thorax. Surgery. 1987;102:433-442.
12. Woods JE, Freedman AM, Brown ML. Lymphoscintigraphy as a guide to treatment in malignant melanoma. Ann Plast Surg. 1989;22:150 -155.
13. Alex JC, Krag DN, Harlow SP, et al. Localization of regional lymph nodes in melanomas of the head and neck. Arch Otolaryngol Head Neck Surg. 1998;124:135-140.
14. Jansen L, Koops HS, Nieweg OE, et al. Sentinel node biopsy for melanoma in the head and neck region. Head Neck. 2000;22:27-33.
15. Schmalbach CE, Nussenbaum B, Rees RS, et al. Reliability of sentinel lymph node mapping with biopsy for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg. 2003;129:61-65.
16. Wagner JD, Park HM, Coleman JJ III, et al. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg. 2000;126:313-321.
17. Wells KE, Rapaport DP, Cruse CW, et al. Sentinel lymph node biopsy in melanoma of the head and neck. Plast Reconstr Surg. 1997;100:591-594.
18. Eicher SA, Clayman GL, Myers JN, et al. A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma. Arch Otolaryngol Head Neck Surg. 2002;128:241-246.
19. Carlson GW, Murray DR, Greenlee R, et al. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg. 2000;126:433-437.
20. Chao C, Wong SL, Edwards MJ, et al. Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol. 2003;10:21-26.
21. Urist MM, Balch CM, Soong SJ, et al. Head and neck melanoma in 534 clinical Stage I patients. A prognostic factors analysis and results of surgical treatment. Ann Surg. 1984;200:769 -775.
22. Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622-3634.
23. Cascinelli N, Morabito A, Santinami M, et al. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. WHO Melanoma Programme. Lancet. 1998;351:793-796.
24. Morton DL, Wanek L, Nizze JA, et al. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg. 1991;214:491-499; discussion 499 -501.
25. Balch CM, Buzaid AC, Soong SJ, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. JClin Oncol. 2001;19:3635-3648.